Ovarian Cancer

Featured Article
Examining Positive Results of Treatment for Patients With Endometrial Cancer
Sarah Temkin, MD, board-certified gynecologic oncologist, and Don Dizon, MD, oncologist specializing in women’s cancers, discuss an ongoing Phase III trial that examines the use of selinexor for the treatment of endometrial cancer, and highlight what they hope to see for the future of care.
Non-BRCA Genes Linked with Breast, Ovarian Cancer
Researchers have identified non-BRCA predisposition genes for breast and ovarian cancer using whole-exome sequencing and gene-phenotype associations. 
Medically Underserved Medicare Beneficiaries Not Receiving Genetic Testing
According to a new study in JAMA, medically underserved Medicare beneficiaries with breast or ovarian cancer rarely receive BRCA tests, which often help with health-related decision-making.

Newsfeed

Examining Positive Results of Treatment for Patients With Endometrial Cancer
Non-BRCA Genes Linked with Breast, Ovarian Cancer
Medically Underserved Medicare Beneficiaries Not Receiving Genetic Testing
HDAC Inhibitors May Offer Option for Ovarian Cancer
BRAF Inhibitors Show Promise for Rare Ovarian Cancer
Researchers Discover Mechanism for PARP Inhibitor Resistance
Comprehensive Cost of Care Task Force Crucial For Oncology
Minimally Invasive Cancer Surgery Less Expensive But Decreases Survival
View More

Interactive Features

Examining Positive Results of Treatment for Patients With Endometrial Cancer
Sarah Temkin, MD, board-certified gynecologic oncologist, and Don Dizon, MD, oncologist specializing in women’s cancers, discuss an ongoing Phase III trial that examines the use of selinexor for the treatment of endometrial cancer, and highlight…
View More
Back to Top